RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.

Grether U, Foxton RH, Gruener S, Korn C, Kimbara A, Osterwald A, Zirwes E, Uhles S, Thoele J, Colé N, Rogers-Evans M, Röver S, Nettekoven M, Martin RE, Adam JM, Fingerle J, Bissantz C, Guba W, Alker A, Szczesniak AM, Porter RF, Toguri TJ, Revelant F, Poirier A, Perret C, Winther L, Caruso A, Fezza F, Maccarrone M, Kelly MEM, Fauser S, Ullmer C.

Open source

DOI: 10.3389/fphar.2024.1426446
Published: 2024-07-12
Container: Front Pharmacol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2024.1426446,
  title = {RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.},
  author = {Grether U and  Foxton RH and  Gruener S and  Korn C and  Kimbara A and  Osterwald A and  Zirwes E and  Uhles S and  Thoele J and  Colé N and  Rogers-Evans M and  Röver S and  Nettekoven M and  Martin RE and  Adam JM and  Fingerle J and  Bissantz C and  Guba W and  Alker A and  Szczesniak AM and  Porter RF and  Toguri TJ and  Revelant F and  Poirier A and  Perret C and  Winther L and  Caruso A and  Fezza F and  Maccarrone M and  Kelly MEM and  Fauser S and  Ullmer C.},
  year = {2024},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2024.1426446},
  url = {https://doi.org/10.3389/fphar.2024.1426446}
}

RIS

TY  - JOUR
TI  - RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.
AU  - Grether U
AU  -  Foxton RH
AU  -  Gruener S
AU  -  Korn C
AU  -  Kimbara A
AU  -  Osterwald A
AU  -  Zirwes E
AU  -  Uhles S
AU  -  Thoele J
AU  -  Colé N
AU  -  Rogers-Evans M
AU  -  Röver S
AU  -  Nettekoven M
AU  -  Martin RE
AU  -  Adam JM
AU  -  Fingerle J
AU  -  Bissantz C
AU  -  Guba W
AU  -  Alker A
AU  -  Szczesniak AM
AU  -  Porter RF
AU  -  Toguri TJ
AU  -  Revelant F
AU  -  Poirier A
AU  -  Perret C
AU  -  Winther L
AU  -  Caruso A
AU  -  Fezza F
AU  -  Maccarrone M
AU  -  Kelly MEM
AU  -  Fauser S
AU  -  Ullmer C.
PY  - 2024
JO  - Front Pharmacol
DO  - 10.3389/fphar.2024.1426446
UR  - https://doi.org/10.3389/fphar.2024.1426446
ER  -

APA

U, G., RH, F., S, G., C, K., A, K., A, O., E, Z., S, U., J, T., N, C., M, R., S, R., M, N., RE, M., JM, A., J, F., C, B., W, G., A, A., AM, S., RF, P., TJ, T., F, R., A, P., C, P., L, W., A, C., F, F., M, M., MEM, K., S, F., & C., U. (2024). RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.. Front Pharmacol. https://doi.org/10.3389/fphar.2024.1426446

Source records

europe-pmc · retrieved 2026-09-27T11:48:25.903Z
doaj · retrieved 2026-09-27T11:48:25.877Z